Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-08

FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nitrofurantoin Macrocrystals from Zydus Pharmaceuticals (USA) Inc., updating an aspect of the approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Macrocrystals) (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN MACROCRYSTALS (NITROFURANTOIN MACROCRYSTALS)